Journal Article > LetterFull Text
Lancet. 1 December 2001; Volume 358 (Issue 9299); 2129-2130.; DOI:10.1016/S0140-6736(01)07185-9
Nathan N, Barry M, Van Herp M, Zeller H
Lancet. 1 December 2001; Volume 358 (Issue 9299); 2129-2130.; DOI:10.1016/S0140-6736(01)07185-9
A yellow fever epidemic erupted in Guinea in September, 2000. From Sept 4, 2000, to Jan 7, 2001, 688 instances of the disease and 225 deaths were reported. The diagnosis was laboratory confirmed by IgM detection in more than 40 patients. A mass vaccination campaign was limited by insufficient international stocks. After the epidemic in Guinea, the International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control decided that 2 million doses of 17D yellow fever vaccine, being stored as part of a UNICEF stockpile, should be used only in response to outbreaks.
Journal Article > LetterFull Text
Emerg Infect Dis. 1 April 2016; Volume 22 (Issue 4); DOI:10.3201/eid2204.151880
Nordenstedt H, Bah EI, de la Vega MA, Barry M, NFaly M, et al.
Emerg Infect Dis. 1 April 2016; Volume 22 (Issue 4); DOI:10.3201/eid2204.151880
Journal Article > ResearchFull Text
Clin Infect Dis. 13 March 2015; Volume 60 (Issue 12); DOI:10.1093/cid/civ202
Barry M, Toure A, Traore FA, Sako FB, Sylla D, et al.
Clin Infect Dis. 13 March 2015; Volume 60 (Issue 12); DOI:10.1093/cid/civ202
In an observational cohort study including 89 Ebola patients, predictor factors of death were analyzed. The crude mortality rate was 43.8%. Myalgia (OR; 4.04; P=0.02), hemorrhage (OR=3.52; P=0.02), and difficulty breathing (OR= 5.75; P=0.01) were independently associated with death.
Journal Article > ReviewFull Text
Lancet. 6 February 2021; Volume 397 (Issue 10273); DOI:10.1016/s0140-6736(21)00130-6
Wise PH, Shiel A, Southard N, Bendavid E, Welsh J, et al.
Lancet. 6 February 2021; Volume 397 (Issue 10273); DOI:10.1016/s0140-6736(21)00130-6
The nature of armed conflict throughout the world is intensely dynamic. Consequently, the protection of non-combatants and the provision of humanitarian services must continually adapt to this changing conflict environment. Complex political affiliations, the systematic use of explosive weapons and sexual violence, and the use of new communication technology, including social media, have created new challenges for humanitarian actors in negotiating access to affected populations and security for their own personnel. The nature of combatants has also evolved as armed, non-state actors might have varying motivations, use different forms of violence, and engage in a variety of criminal activities to generate requisite funds. New health threats, such as the COVID-19 pandemic, and new capabilities, such as modern trauma care, have also created new challenges and opportunities for humanitarian health provision. In response, humanitarian policies and practices must develop negotiation and safety capabilities, informed by political and security realities on the ground, and guidance from affected communities. More fundamentally, humanitarian policies will need to confront a changing geopolitical environment, in which traditional humanitarian norms and protections might encounter wavering support in the years to come.